Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epidiolex for Cannabis Use Disorder
NCT03102918Phase 1Completed
- Sponsor
- McLean Hospital
- Start
- Feb 2016
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in cannabis use disorder (CUD) comparing Cannabidiol with Placebo (2 arms). Primary endpoints: Quantitative THC levels at Week 6 and Self-report by Timeline Follow Back at Week 6. Started Feb 2016; status: completed.
02
Drugs
cannabidiol
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT03102918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03102918.